Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Stem Cell Transplantation for Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Docetaxel in Node Positive Adjuvant Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Total Marrow Irradiation for Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
- Status
- TERMINATED
- Phase
- PHASE1
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2